3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
2
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
1617
Carcinoma, Renal Cell
497
Urinary Bladder Neoplasms
459
Carcinoma, Transitional Cell
233
Breast Neoplasms
225
Kidney Neoplasms
214
Neoplasms
190
Carcinoma, Non-Small-Cell Lung
173
Colorectal Neoplasms
168
Ovarian Neoplasms
161
Melanoma
161
Neoplasm Metastasis
142
Lung Neoplasms
127
Non-Muscle Invasive Bladder Neoplasms
104
Pancreatic Neoplasms
101
Stomach Neoplasms
99
Uterine Cervical Neoplasms
91
Squamous Cell Carcinoma of Head and Neck
86
Endometrial Neoplasms
82
Carcinoma, Hepatocellular
76
Sarcoma
75
Esophageal Neoplasms
71
Head and Neck Neoplasms
68
Adenocarcinoma
67
Triple Negative Breast Neoplasms
65
Colonic Neoplasms
53
Testicular Neoplasms
52
Disease
47
Wilms Tumor
46
Urologic Neoplasms
45
Interventions
olaparib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fanconi Anemia, Complementation Group D1
×
Genitourinary
×
1 year
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled